WHO WE ARE
The PACT Steering Committee, comprised of a collaborative team of senior stakeholders from across the cancer clinical trial continuum, led by Colorectal Cancer Canada, came together to define the vision, mission and key goals for PACT.
STEERING COMMITTEE MEMBERS
Stéphanie Michaud
President & CEO
BioCanRx
Martine Elias
Executive Director
Myeloma Canada
Judy Needham
Chair of the Patient Representatives Committee
Canadian Cancer Trials Group (CCTG)
Sarita Benchimol
Chairman of the PACT Steering Committee
Richard Fajzel
INDEPENDANT SENIOR CONSULTANT, FORMER PRESIDENT and CEO of EXACTIS INNOVATION
Sabrina Hanna
Chief Innovation Officer
The Cancer Collaborative
Barry D. Stein
President & CEO
Colorectal Cancer Canada
PAST STEERING COMMITTEE MEMBERS
Vatche Bartekian
President
Vantage BioTrials
Dominique Johnson
Managing Director
Groupe McPeak-Sirois de recherche clinique eN cancer du sein
Stephen Sundquist
Executive Director
Canadian Cancer Clinical Trials Network (3CTN)
KEY RESPONSIBILITIES:
PACT oversight, governance and continuous improvement
Create overarching “business plan” and endpoints
Promote and elevate the PACT Initiative
Foster Collaborations – convenor of key stakeholders
Ecosystem Collaborative:
Includes parties with concerns or interests in an organization, endeavor, or initiative.
Stakeholders include but are not limited to:
- Governmental institutions and agencies
- Medical Researchers
- Patients/Patient Groups
- Research sponsors
- Clinical Research Networks
- Clinicians
- Academics
- Pharmaceutical/Biotech Companies
- Regulatory bodies (internal/external)
A special Thank You to Colorectal Cancer Canada (CCC) for its involvement.
Colorectal Cancer Canada is the nation’s not for profit colorectal cancer patient organization dedicated to colorectal cancer awareness and education, supporting patients and their caregivers and advocating on their behalf.